Sharon Hanegraaf
Vice President of Regulatory Affairs / Argenica Therapeutics
| Rank | Company | # | |
|---|---|---|---|
| 110th | - | Argenica Therapeutics | $3.21m |
| 122nd | - | EVE Health Group | $1.74m |
| 123rd | - | InteliCare | $1.58m |
| 124th | - | Zimi | $1.56m |
| 125th | - | 333D | $1.51m |
| Rank | Company | 1 Yr | 5 Yr |
|---|---|---|---|
| 1637th | Dome Gold Mines | -84.61% | -30.11% |
| 1638th | Tlou Energy | -85% | -43.26% |
| 1639th | Argenica Therapeutics | -85.19% | 0% |
| 1640th | BauMart Holdings | -85.37% | -48.29% |
| 1641st | Helios Energy | -85.6% | -55.58% |
|
NEWS: Tagged in Board moves August 7, 2025 | 07 Aug 2025 |
|
NEW ROLE: Vice President of Regulatory Affairs, Argenica Therapeutics | 07 Aug 2025 |
Access to our data for Sharon Hanegraaf is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Sharon Hanegraaf is linked to 1 organisation which is included in 1 list - Public Companies - Industrial WA.
To see the data you will need to Subscribe.